Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP432462.RAeNFJ-23dq3phqlLPjXm6vQwXhIYfSP6B385DGVWaVII130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP432462.RAeNFJ-23dq3phqlLPjXm6vQwXhIYfSP6B385DGVWaVII130_assertion type Assertion NP432462.RAeNFJ-23dq3phqlLPjXm6vQwXhIYfSP6B385DGVWaVII130_head.
- NP432462.RAeNFJ-23dq3phqlLPjXm6vQwXhIYfSP6B385DGVWaVII130_assertion wasGeneratedBy ECO_0000203 NP432462.RAeNFJ-23dq3phqlLPjXm6vQwXhIYfSP6B385DGVWaVII130_provenance.
- NP432462.RAeNFJ-23dq3phqlLPjXm6vQwXhIYfSP6B385DGVWaVII130_assertion wasDerivedFrom befree-20140225 NP432462.RAeNFJ-23dq3phqlLPjXm6vQwXhIYfSP6B385DGVWaVII130_provenance.
- NP432462.RAeNFJ-23dq3phqlLPjXm6vQwXhIYfSP6B385DGVWaVII130_assertion SIO_000772 24011934 NP432462.RAeNFJ-23dq3phqlLPjXm6vQwXhIYfSP6B385DGVWaVII130_provenance.
- NP432462.RAeNFJ-23dq3phqlLPjXm6vQwXhIYfSP6B385DGVWaVII130_assertion evidence source_evidence_literature NP432462.RAeNFJ-23dq3phqlLPjXm6vQwXhIYfSP6B385DGVWaVII130_provenance.
- NP432462.RAeNFJ-23dq3phqlLPjXm6vQwXhIYfSP6B385DGVWaVII130_assertion description "[These studies identify dual targeted inhibitors of PI3K/mTOR in combination with inhibitors of RAS/ERK signalling as a potentially effective new approach to treating ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432462.RAeNFJ-23dq3phqlLPjXm6vQwXhIYfSP6B385DGVWaVII130_provenance.